1. Home
  2. BOLT vs JCTC Comparison

BOLT vs JCTC Comparison

Compare BOLT & JCTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • JCTC
  • Stock Information
  • Founded
  • BOLT 2015
  • JCTC 1953
  • Country
  • BOLT United States
  • JCTC United States
  • Employees
  • BOLT N/A
  • JCTC N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • JCTC
  • Sector
  • BOLT Health Care
  • JCTC
  • Exchange
  • BOLT Nasdaq
  • JCTC NYSE
  • Market Cap
  • BOLT 16.8M
  • JCTC 13.9M
  • IPO Year
  • BOLT 2021
  • JCTC 1996
  • Fundamental
  • Price
  • BOLT $0.37
  • JCTC $3.88
  • Analyst Decision
  • BOLT Hold
  • JCTC
  • Analyst Count
  • BOLT 5
  • JCTC 0
  • Target Price
  • BOLT $1.13
  • JCTC N/A
  • AVG Volume (30 Days)
  • BOLT 145.0K
  • JCTC 12.0K
  • Earning Date
  • BOLT 05-13-2025
  • JCTC 04-14-2025
  • Dividend Yield
  • BOLT N/A
  • JCTC N/A
  • EPS Growth
  • BOLT N/A
  • JCTC N/A
  • EPS
  • BOLT N/A
  • JCTC N/A
  • Revenue
  • BOLT $7,690,000.00
  • JCTC $47,432,094.00
  • Revenue This Year
  • BOLT N/A
  • JCTC N/A
  • Revenue Next Year
  • BOLT $77.45
  • JCTC N/A
  • P/E Ratio
  • BOLT N/A
  • JCTC N/A
  • Revenue Growth
  • BOLT N/A
  • JCTC N/A
  • 52 Week Low
  • BOLT $0.30
  • JCTC $3.26
  • 52 Week High
  • BOLT $1.34
  • JCTC $5.69
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 48.52
  • JCTC N/A
  • Support Level
  • BOLT $0.33
  • JCTC N/A
  • Resistance Level
  • BOLT $0.39
  • JCTC N/A
  • Average True Range (ATR)
  • BOLT 0.04
  • JCTC 0.00
  • MACD
  • BOLT 0.00
  • JCTC 0.00
  • Stochastic Oscillator
  • BOLT 66.06
  • JCTC 0.00

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About JCTC JEWETT-CAMERON TRADING CO

Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.

Share on Social Networks: